SEC Form 4
Moderna, Inc. (MRNA) insider trading
In the 12 months to Oct 23, 2026, 4 MRNA insiders reported open-market sales of $52.7M across 12 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $52.7M
- 12 filings · 4 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 10 of 12
- $51.5M of $52.7M sold (98%)
Who traded MRNA, and when
- Sale
- Sale, pre-arranged (10b5-1)
MRNA daily close from Oct 23, 2025 to Oct 22, 2026, between $22.36 and $245.81, last $202.63. 12 sale and 0 purchase filings by 4 insiders, marked at their filing dates. Stephen Hoge, President: sold $45.4M across 6 filings, first filed Feb 25, 2026, last Oct 16, 2026. James M. Mock, Chief Financial Officer: sold $4.7M across 1 filing, first filed Sep 14, 2026, last Sep 14, 2026. Shannon Thyme Klinger, Chief Legal Officer: sold $1.4M across 3 filings, first filed Mar 3, 2026, last Sep 3, 2026. Noubar Afeyan, Director: sold $1.1M across 2 filings, first filed Dec 15, 2025, last May 22, 2026.
Largest mark · tap a row for others
Stephen Hoge · President
Sale $17,013,538
78,369 shares at $217.10 avg
Filed Oct 16, 2026 · traded Oct 14
Pre-arranged (10b5-1) · close on filing date $218.01
Stephen Hoge · President
President
$45.4M soldJames M. Mock · Chief Financial Officer
Chief Financial Officer
$4.7M soldShannon Thyme Klinger · Chief Legal Officer
Chief Legal Officer
$1.4M soldNoubar Afeyan · Director
Director
$1.1M soldHas Moderna, Inc.'s CEO sold stock?
No. Stephane Bancel (CEO) made no open-market sales filed as CEO in the last 12 months.
Open-market trades
12 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Stephen Hoge | President | $45.4M | — | 6 | 100% of sales | |
| James M. Mock | Chief Financial Officer | $4.7M | — | 1 | 100% of sales | |
| Shannon Thyme Klinger | Chief Legal Officer | $1.4M | — | 3 | 100% of sales | |
| Noubar Afeyan | Director | $1.1M | — | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Stephen Hoge President | SalePre-arranged (10b5-1) | 78,369 | $217.10 | $17.0M | 1,636,565 | |
traded | Stephen Hoge President | SalePre-arranged (10b5-1) | 80,575 | $145.10 | $11.7M | 1,562,029 | |
traded | James M. Mock Chief Financial Officer | SalePre-arranged (10b5-1) | 34,836 | $134.49 | $4.7M | 59,375 | |
traded | Shannon Thyme Klinger Chief Legal Officer | SalePre-arranged (10b5-1) | 3,471 | $139.95 | $485.8K | 74,129 | |
traded | Stephen Hoge President | SalePre-arranged (10b5-1) | 53,336 | $67.60 | $3.6M | 1,483,848 | |
traded | Stephen Hoge President | SalePre-arranged (10b5-1) | 53,336 | $51.37 | $2.7M | 1,483,848 | |
traded | Shannon Thyme Klinger Chief Legal Officer | SalePre-arranged (10b5-1) | 3,471 | $50.00 | $173.6K | 67,468 | |
traded | Noubar Afeyan Director | Sale | 9,263 | $46.84 | $433.9K | 3,924 | |
traded | Stephen Hoge President | SalePre-arranged (10b5-1) | 53,336 | $48.40 | $2.6M | 1,477,997 | |
traded | Shannon Thyme Klinger Chief Legal Officer | SalePre-arranged (10b5-1) | 13,885 | $52.29 | $726.0K | 59,689 | |
traded | Stephen Hoge President | SalePre-arranged (10b5-1) | 160,009 | $48.84 | $7.8M | 1,457,427 | |
traded | Noubar Afeyan Director | Sale | 23,853 | $29.49 | $703.3K | 3,924 |
GET /stocks/filings/vX/form-4?tickers=MRNA&filing_date.gte=2025-10-23&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"MRNA"
],
"issuer_cik": "0001682852",
"owner_cik": "0001760669",
"accession_number": "0001682852-26-000187",
"form_type": "4",
"filing_date": "2026-10-16",
"period_of_report": "2026-10-14",
"issuer_name": "Moderna, Inc.",
"issuer_trading_symbol": "MRNA",
"owner_name": "Hoge Stephen",
"is_officer": true,
"officer_title": "President",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-14",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 38774,
"transaction_price_per_share": 213.47,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 1599708,
"transaction_value": 8277085.78,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026."
},
{
"id": "F2",
"description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.03 to $213.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."
}
]
},
{
"tickers": [
"MRNA"
],
"issuer_cik": "0001682852",
"owner_cik": "0001760669",
"accession_number": "0001682852-26-000187",
"form_type": "4",
"filing_date": "2026-10-16",
"period_of_report": "2026-10-14",
"issuer_name": "Moderna, Inc.",
"issuer_trading_symbol": "MRNA",
"owner_name": "Hoge Stephen",
"is_officer": true,
"officer_title": "President",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-14",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 450,
"transaction_price_per_share": 214.15,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 1599258,
"transaction_value": 96367.5,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026."
},
{
"id": "F3",
"description": "The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.05 to $214.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 139 records
- Option exercises76 records
- Tax withholding53 records
- Tax withholding (sold to cover)6 records
- Grants and awards4 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MRNA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.